Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H22O6 |
Molecular Weight | 358.3851 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12OC(=O)[C@](O)(C=C1)[C@]3(C)CC[C@@]4([H])C(=O)O[C@@H](C[C@@]4(C)[C@]23[H])C5=COC=C5
InChI
InChIKey=AALLCALQGXXWNA-DURQJQQASA-N
InChI=1S/C20H22O6/c1-18-9-14(11-5-8-24-10-11)25-16(21)12(18)3-6-19(2)15(18)13-4-7-20(19,23)17(22)26-13/h4-5,7-8,10,12-15,23H,3,6,9H2,1-2H3/t12-,13-,14-,15-,18+,19+,20+/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/22227329
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22227329
Columbin is a diterpenoid furanolactone, was isolated from the plant species Tinspora bakis. It displays anti-inflammatory activity, protects from azoxymethane-induced rat colon carcinogenesis and possess trypanocidal mechanism.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL230 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22227329 |
53.1 µM [IC50] | ||
Target ID: GO:0070508 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16206831 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Structure of columbin, a diterpenoid furanolactone from Tinospora cordifolia Miers. | 1989 Feb 15 |
|
A bitter diterpenoid furanolactone columbin from Calumbae Radix inhibits azoxymethane-induced rat colon carcinogenesis. | 2002 Sep 26 |
|
In vitro and in vivo anti-inflammatory activities of columbin through the inhibition of cycloxygenase-2 and nitric oxide but not the suppression of NF-κB translocation. | 2012 Mar 5 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12065087
Curator's Comment: https://www.ncbi.nlm.nih.gov/pubmed/22227329
In anti-canrogenesis experiments rats were fed by experimental diets, made by mixing columbin at doses of 4, 20, and 100 ppm with a powdered CE-2 basal diet. Anti-inflammatory activity was evaluated in carrageenan-induced mice paw oedema test. Columbin was intra-peritoneally administered to mice at the dose of 30, 100, 300 and 700 mg/kg.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22227329
COX-2 activity was tested using COX-inhibitor screening kit (Cayman Chemical, USA). This assay measures the production of PGF2-alpha generated by SnCl2, in the presence of PGH2. Columbin inhibits COX-2 with IC50 of 53 uM.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
KKI91P85GE
Created by
admin on Fri Dec 15 19:41:20 GMT 2023 , Edited by admin on Fri Dec 15 19:41:20 GMT 2023
|
PRIMARY | |||
|
m3746
Created by
admin on Fri Dec 15 19:41:20 GMT 2023 , Edited by admin on Fri Dec 15 19:41:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
546-97-4
Created by
admin on Fri Dec 15 19:41:20 GMT 2023 , Edited by admin on Fri Dec 15 19:41:20 GMT 2023
|
PRIMARY | |||
|
C062514
Created by
admin on Fri Dec 15 19:41:20 GMT 2023 , Edited by admin on Fri Dec 15 19:41:20 GMT 2023
|
PRIMARY | |||
|
188289
Created by
admin on Fri Dec 15 19:41:20 GMT 2023 , Edited by admin on Fri Dec 15 19:41:20 GMT 2023
|
PRIMARY | |||
|
DTXSID70969857
Created by
admin on Fri Dec 15 19:41:20 GMT 2023 , Edited by admin on Fri Dec 15 19:41:20 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD